Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.93% | 54.04 | 0.9% | $2015.04m | |
| JNJ | Johnson & Johnson | -0.82% | 165.21 | 0.7% | $968.47m | |
| ABBV | AbbVie, Inc. | -1.62% | 133.02 | 1.9% | $895.75m | |
| MRK | Merck & Co., Inc. | -0.69% | 80.73 | 0.7% | $855.87m | |
| BMY | Bristol-Myers Squibb Co. | -0.17% | 64.61 | 1.0% | $688.01m | |
| LLY | Eli Lilly & Co. | -0.76% | 243.20 | 1.1% | $618.76m | |
| AZN | AstraZeneca Plc | 1.16% | 60.17 | 1.0% | $241.82m | |
| NVS | Novartis AG | -0.75% | 88.18 | 0.2% | $194.25m | |
| GSK | GlaxoSmithKline Plc | -1.77% | 44.88 | 0.2% | $162.29m | |
| NVO | Novo Nordisk A/S | -1.86% | 95.48 | 0.1% | $152.14m | |
| VTRS | Viatris, Inc. | -0.54% | 14.64 | 0.0% | $140.27m | |
| RGEN | Repligen Corp. | -0.59% | 188.46 | 6.7% | $99.30m | |
| IMMX | Immix Biopharma, Inc. | -4.24% | 5.42 | 0.0% | $85.02m | |
| ALLK | Allakos, Inc. | -3.37% | 7.18 | 0.0% | $84.68m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.87% | 116.04 | 0.0% | $72.25m |
Company Profile
CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism; as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Boston, MA.